Symmetry Partners, LLC Biogen Inc. Transaction History

Symmetry Partners, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$253.3 - $285.89 $79,536 - $89,769	-314 Reduced 19.54%	1,293 $332,000
Q2 2023 Jul 05, 2023	SELL	$275.25 - $318.06 $184,692 - $213,418	-671 Reduced 29.46%	1,607 $458,000
Q3 2022 Oct 03, 2022	BUY	$194.69 - $268.46 $131,221 - $180,942	674 Added 42.02%	2,278 $608,000
Q2 2022 Jul 11, 2022	BUY	$187.54 - $223.02 $300,814 - $357,724	1,604 New	1,604 $327,000
Q4 2021 Jan 11, 2022	SELL	$223.92 - $287.77 $637,052 - $818,705	-2,845 Closed	0 $0
Q3 2021 Oct 18, 2021	SELL	$282.99 - $369.05 $104,989 - $136,917	-371 Reduced 11.54%	2,845 $798,000
Q1 2021 May 03, 2021	SELL	$242.95 - $284.63 $81,631 - $95,635	-336 Reduced 9.46%	3,216 $900,000
Q4 2020 Feb 18, 2021	SELL	$236.26 - $355.63 $491,893 - $740,421	-2,082 Reduced 36.95%	3,552 $870,000
Q3 2020 Nov 03, 2020	BUY	$264.77 - $305.71 $779,482 - $900,010	2,944 Added 109.44%	5,634 $1.6 Million
Q2 2020 Jul 20, 2020	BUY	$258.66 - $342.55 $695,795 - $921,459	2,690 New	2,690 $720,000
Q3 2019 Nov 04, 2019	SELL	$217.44 - $243.88 $374,649 - $420,205	-1,723 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$219.29 - $241.72 $142,099 - $156,634	-648 Reduced 27.33%	1,723 $403,000
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $133,710 - $209,138	617 Added 35.18%	2,371 $560,000
Q4 2018 May 22, 2019	BUY	$278.5 - $352.75 $488,489 - $618,723	1,754 New	1,754 $528,000

1,006

129M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Symmetry Partners, LLC with notifications on news.